Wednesday, 25 May, 2022 - 16:38
Board Moves May 25, 2022
Our board moves wrap includes Michael Naylor, Susan Field, Ray Shorrocks, Simon Jackson, Rod Heale, Vin Vassallo, Mark Freeman, David Koch, Donald Strang, Richard Treagus, and Jeffrey Lee.
Dr Richard Treagus is a medical doctor with extensive ASX experience, and a background in pharmaceutical sales and marketing.
After a period as a medical director of WyethAyerst (now Pfizer), Dr Treagus became the commercial director of Aspen Pharmacare in South Africa where he was responsible for all sales, marketing and business development for pharmacy and consumer products. He was also the general manager of Sigma Pharmaceuticals in Melbourne, managing director and chief executive of ASX-listed Acrux, and executive chair of ASX-listed Neuren Pharmaceuticals.
Dr Treagus graduated with an MB ChB (Medicine and Surgery, First Class Honours), Master of Medicine, and an MBA from universities in South Africa.
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
694th | Gibb River Diamonds">Gibb River Diamonds | 9.94% | 7.25% |
695th | HHY Fund">HHY Fund | 9.93% | 2.3% |
696th | BTC Health">BTC Health | 9.67% | -10.64% |
697th | Ark Mines">Ark Mines | 9.53% | 46.58% |
698th | Katana Capital">Katana Capital | 9.37% | 10.67% |
![]() |
NEW ROLE: Non-Executive Director, Firebrick Pharma | 25 May 2022 |
Our board moves wrap includes Michael Naylor, Susan Field, Ray Shorrocks, Simon Jackson, Rod Heale, Vin Vassallo, Mark Freeman, David Koch, Donald Strang, Richard Treagus, and Jeffrey Lee.
Access to our data for Richard Treagus is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Richard Treagus is linked to 4 organisations which are included in 1 list - Public Companies - non WA.
To see the data you will need to Subscribe.